title: Bone marrow transplantation in Hong Kong.
abstract: Comprehensive programmes for BMT started in Hong Kong in 1990. As of September 1993, there are a total of 13 BMT beds in Government-funded University Hospitals performing about 110 transplants per year or 18 transplants per million population per year. So far, 194 transplants were performed: allogeneic BMT (72.2%), autologous BMT (11.8%), matched unrelated donor BMT (8.8%), identical twin BMT (1.5%), mismatched BMT (2.1%) and second BMT (3.6%). The major indication was haematological malignancy (84%). About 40% of the patients were prepared by chemotherapy alone. A combination of CsA and short MTX was the commonest GVHD prophylaxis. The incidence of GVHD was the same as in the Caucasians. Results of transplant outcome were comparable to those reported by the International Bone Marrow Transplant Registry.
authors.affiliation: Department of Medicine, Queen Mary Hospital, University of Hong Kong.
authors.forename: E K
authors.initials: EK
authors.lastname: Chiu
authors.forename: P
authors.initials: P
authors.lastname: Yuen
authors.forename: T K
authors.initials: TK
authors.lastname: Chan
mesh_terms: D016026:Bone Marrow Transplantation / Q000276:immunology; D016572:Cyclosporine / Q000627:therapeutic use; D005192:Family Health; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control; D006648:Histocompatibility / Q000276:immunology; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009313:National Health Programs; D014019:Tissue Donors; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
chemical_list: D016572:Cyclosporine; D008727:Methotrexate